Soiken Holdings Inc. | Balance Sheet

Fiscal year is July-June. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,706
3,085
3,369
3,339
2,972
Total Accounts Receivable
143
236
414
547
679
Inventories
359
365
408
761
1,041
Other Current Assets
44
39
61
118
205
Total Current Assets
3,252
3,725
4,251
4,764
4,898
Net Property, Plant & Equipment
17
21
35
47
38
Total Investments and Advances
984
566
568
576
547
Intangible Assets
17
25
25
55
68
Other Assets
52
54
59
97
100
Total Assets
4,322
4,391
4,939
5,542
5,653
ST Debt & Current Portion LT Debt
-
-
-
33
-
Accounts Payable
49
46
145
188
262
Income Tax Payable
16
18
112
111
91
Other Current Liabilities
170
188
351
519
649
Total Current Liabilities
235
253
608
852
1,002
Long-Term Debt
-
-
-
18
-
Provision for Risks & Charges
-
-
-
9
10
Deferred Taxes
11
10
15
7
4
Total Liabilities
246
263
624
888
1,018
Common Equity (Total)
4,074
4,128
4,231
4,368
4,495
Total Shareholders' Equity
4,074
4,128
4,231
4,368
4,495
Total Equity
4,076
4,128
4,315
4,654
4,635
Liabilities & Shareholders' Equity
4,322
4,391
4,939
5,542
5,653
Accumulated Minority Interest
-
3
84
286
140

About Soiken Holdings

View Profile
Address
Senri Life Science Center, 13/F
Osaka Osaka 560
Japan
Employees -
Website http://www.soiken.com
Updated 07/08/2019
Soiken Holdings Inc. engages in the development of biomarkers and assessment systems. Its operates through the following segments: Biological Evaluation System, Health Care Support, Cosmetics, Marketing, Health Supplement and Functional materials. The Biological Evaluation System segment performs clinical evaluation tests on the function and safety of food.